Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer.
Yukihiro UmedaMiwa MorikawaMasaki AnzaiShingo AmeshimaMaiko KadowakiYuko WasedaHiroko ShigemiTetsuya TsujikawaYasushi KiyonoHidehiko OkazawaTamotsu IshizukaPublished in: Journal for immunotherapy of cancer (2021)
UMIN 000020707.